We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

INGM:NYSEIngram Micro Holding Corporation Analysis

Data as of 2026-05-19 - not real-time

$25.72

Latest Price

6/10Risk

Risk Level: Medium

Executive Summary

Ingram Micro has delivered strong top‑line momentum, with revenue growth highlighted in the latest earnings call and forward earnings per share showing notable improvement. Operating margins remain thin but the company is generating positive free cash flow and maintains a modest dividend payout. Technical analysis shows the 20‑day moving average comfortably above the 50‑day average, supporting a bullish bias, while the RSI near the neutral zone suggests limited upside momentum in the short run. The MACD histogram is negative, indicating lingering bearish pressure, and the stock is trading near a well‑defined support level with increasing volume, which may provide a cushion for a bounce. A recent secondary offering by a principal shareholder introduces dilution risk, yet the market’s “Extreme Greed” sentiment and the DCF‑derived fair value well above the current price point imply significant upside potential. Overall, the blend of solid revenue expansion, attractive valuation relative to peers, and a sustainable dividend makes the stock appealing for patient investors.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Negative MACD histogram signaling short‑term bearish pressure
  • Proximity to support level with rising volume
  • Potential dilution from secondary stock offering

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Revenue growth trajectory and improving forward EPS
  • Undervalued relative to DCF fair value and industry peers
  • Sustainable dividend with low payout ratio

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Diversified global footprint reducing geographic concentration risk
  • Continued expansion in cloud and advanced solutions
  • Attractive valuation metrics and strong cash generation

Key Metrics & Analysis

Financial Health

Revenue Growth13.70%
Profit Margin0.66%
P/E Ratio16.9
ROE8.86%
ROA3.20%
Debt/Equity90.51
P/B Ratio1.4
Op. Cash Flow$138.7M
Free Cash Flow$561.8M
Industry P/E38.2

Technical Analysis

TrendBullish
RSI40.3
Support$25.16
Resistance$31.38
MA 20$28.23
MA 50$25.95
MA 200$22.37
MACDBearish
VolumeIncreasing
Fear & Greed Index89.61

Valuation

Fair Value$43.47
Target Price$31.35
Upside/Downside21.87%
GradeUndervalued
TypeBlend
Dividend Yield1.26%

Risk Assessment

Beta1.46
Volatility44.91%
Sector RiskMedium
Reg. RiskLow
Geo RiskMedium
Currency RiskMedium
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.